Table 3.
Effects of Treatment for Obstructive Sleep Apnea on Asthma Outcomes
Reference | Design/Sample | Assessment | Results | Limitations |
---|---|---|---|---|
CPAP treatment | ||||
Teodorescu et al., 2012 (62) | Cross-sectional | OSA: SA-SDQ and PSG | • ↓ Daytime asthma symptoms (*OR, 0.46) | Objective CPAP adherence not available |
n = 132 with OSA, 75 on CPAP | Asthma: physician diagnosis | |||
Teodorescu et al., 2013 (7) | Cross-sectional | OSA: PSG | • ↓ Risk of severe asthma (more in older vs. younger patients, by 91% vs. 57%) | PSG-derived OSA severity or objective CPAP adherence not available |
Age 18–59 yr vs. 60–75 yr | Asthma: physician diagnosis | |||
n = 140 | ||||
Kauppi et al., 2016 (97) | Longitudinal, retrospective study | OSA: physician diagnosis and CPAP ≥3 mo | • ↓ Asthma severity (ACT and VAS) | Generalizability limited with high CPAP adherence (6.3 h daily) |
n = 152 | Asthma: on asthma medication | |||
Wang et al., 2017 (63) | Longitudinal, retrospective study | OSA: PSG | • ↓ The annual decline in FEV1 in severe OSA | No control group |
n = 77 | Asthma: spirometry | |||
Lafond et al., 2007 (68) | Interventional: CPAP × 6 wk | OSA: PSG (AHI ≥ 15/h) and CPAP titration | • No difference in methacholine challenge test | Per-protocol analysis of 13 patients with ≥4 h daily CPAP use |
n = 20 | Asthma: ATS criteria | • ↑ Asthma-specific quality of life | ||
Serrano-Pariente et al., 2017 (69) | Interventional: CPAP × 6 mo | OSA: AHI ≥20/h | • ↑ Asthma control, disease-specific quality of life | No control group |
n = 99 | Asthma: physician diagnosis | • ↓ Bronchial reactivity (reduced proportion of patients with positive bronchodilator response), exhaled NO | ||
Other OSA treatments | ||||
Bachour et al., 2016 (71) | Cross-sectional survey, n = 303 | OSA: referred for oral appliance treatment | • ↑ ACT with oral appliance treatment | No control group |
Asthma, n = 18 | Asthma: physician diagnosis and asthma medication use | |||
Omana et al., 2010 (73) | Retrospective bariatric cohort | OSA: CPAP use | • Self-reported improvement in symptoms or cessation of treatment; in asthma 21/31, in OSA 14/32 | Lack of validated questionnaire |
Follow-up 17 mo, n = 123 | ||||
Asthma, n = 31 | Asthma: use of asthma medications | |||
OSA, n = 32 | ||||
Simard et al., 2004 (72) | Prospective bariatric cohort | OSA: self-reported | • Self-reported improvement in asthma control in 23/34 | Lack of validated questionnaire |
Follow-up 2 yr, n = 398 | Asthma: self-reported | |||
Asthma, n = 34 | ||||
OSA, n = 47 | ||||
OSA and asthma, n = 18 |
Definition of abbreviations: ↓ = decreased; ↑ = increased; ACT = asthma control test; AHI = apnea–hypopnea index; ATS = American Thoracic Society; CPAP = continuous positive airway pressure; OR = odds ratio; OSA = obstructive sleep apnea; PSG = polysomnography; SA-SDQ = sleep apnea scale of the Sleep Disorders Questionnaire; VAS = visual analog scale.
Statistically significant OR.